Alphatec Holdings (ATEC) Stock Analysis & Winston Score
Alphatec Holdings makes surgical tools and implants used to fix problems with the spine. Its products help surgeons treat conditions like scoliosis, herniated discs, and spinal instability. The company sells primarily to hospitals and spine surgeons across the United States, competing in the broader orthopedic and spine device market. Alphatec earns revenue by selling its hardware — things like screws, rods, and spacers — along with the instruments surgeons use to implant them. It operates almost entirely in the U.S. and generates roughly $600 million in annual revenue. The company has built a niche around a surgical approach called lateral spine surgery, which it has invested heavily in developing and training surgeons to use. However, Alphatec is not yet profitable, with negative operating and returns on capital, meaning its main challenge is converting strong gross margins into actual earnings as it continues spending heavily on sales force expansion and product development.
Winston Score: 35/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (10/30)
- Growth: Good (13/20)
- Cash Flow: Weak (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $9.48
Market Cap: $1.5B
Sector: Healthcare
Industry: Medical - Devices
Exchange: NASDAQ
